Ally Bridge Group (NY) LLC - FREELINE THERAPEUTICS HLDGS ownership

Back to all holdings Add to watchlist

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Ally Bridge Group (NY) LLC ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2021$3,274,000
-34.9%
401,747
-1.7%
0.81%
-15.7%
Q1 2021$5,027,000
-35.2%
408,726
-3.8%
0.96%
-27.5%
Q4 2020$7,761,000–425,000–1.33%–
 Download
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,507$6,217,9909.26%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders